Provided by Tiger Trade Technology Pte. Ltd.

Avis Budget

146.88
+0.27000.18%
Post-market: 146.880.00000.00%19:40 EDT
Volume:260.36K
Turnover:38.39M
Market Cap:5.19B
PE:-8.19
High:149.85
Open:146.39
Low:146.39
Close:146.61
52wk High:847.70
52wk Low:85.96
Shares:35.32M
Float Shares:14.85M
Volume Ratio:1.03
T/O Rate:1.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-17.9408
EPS(LYR):-25.2557
ROE:5800.00%
ROA:2.70%
PB:-1.53
PE(LYR):-5.82

Loading ...

UBS Reaffirms Their Buy Rating on CAR Group (WN6)

TIPRANKS
·
Jun 23

Closing Bell Movers: Avis Budget jumps over 6% on Pentwater settlement

TIPRANKS
·
Jun 23

Stocks to Watch: Primoris Services, Avis Budget, Nexentis Technologies

Dow Jones
·
Jun 23

Avis Budget Reaches $650 Million Legal Settlement Agreement

TIPRANKS
·
Jun 23

Legend Biotech Prices $226 Million ADS Offering to Bolster Cell Therapy Expansion

TIPRANKS
·
Jun 23

Avis Budget Group Shares Rise 6.9% to $199.09 in Relatively Light After the Bell Trading, Announced Settlement Agreement With Pentwater Capital Management

THOMSON REUTERS
·
Jun 23

Avis Budget enters settlement agreement with Pentwater Capital Management

TIPRANKS
·
Jun 23

Movement Alert|Avis Budget Group Rises 6.83% in After-Hours Trading, Settlement Reached with Pentwater Capital Management

Market Focus
·
Jun 23

Avis Budget Group - Settlement Amount Set at $650 Mln in Cash - SEC Filing

THOMSON REUTERS
·
Jun 23

Avis Budget Group - Enters Settlement Agreement With Pentwater Capital Management on June 19, 2026 - SEC Filing

THOMSON REUTERS
·
Jun 23

Avis Budget reaches USD 650 million settlement with Pentwater in short-swing profits lawsuit

Reuters
·
Jun 23

CARsgen Wins First-Ever Global Approval for Solid-Tumor CAR T Therapy in China

TIPRANKS
·
Jun 22

CARSGEN-B Receives NMPA Approval for Claudin18.2 CAR-T Therapy Kelimei®

Stock News
·
Jun 22

Hong Kong Shares Surge as CARSGEN-B Achieves Landmark Approval for First Solid Tumor CAR-T Therapy

Stock News
·
Jun 22

How Early Allogeneic CAR T Results At CARsgen (SEHK:2171) Have Changed Its Investment Story

Simply Wall St.
·
Jun 19

Movement Alert|Avis Budget Group Rises 5.32% in Regular Trading, Trading at $189.8

Market Focus
·
Jun 19

Bristol Myers Squibb (BMY) Reports Strong Myeloma Trial Results And Early CAR T Progress

Simply Wall St.
·
Jun 18

CARsgen Therapeutics Holdings (SEHK:2171) Stock Looks Rich Even After New CAR T Data

Simply Wall St.
·
Jun 16

Legend Biotech Unveils Strong First-in-Human Data for In Vivo CAR-T LB2501 at EHA 2026

TIPRANKS
·
Jun 15

Legend Biotech Says In Vivo CAR-T Candidate LB2501 Delivers Early Proof-of-Concept in Lymphoma

MT Newswires Live
·
Jun 15